TYBR Health
It develops the B3 GEL® System, a medical technology platform for healthcare providers, and is using Series A capital to broaden patient access.
Overview
TYBR Health builds the B3 GEL® System, a healthcare technology product positioned for clinical use and broader patient access. The company targets healthcare providers and care settings that can adopt the system as part of patient treatment workflows. The company’s key disclosed differentiator is its proprietary B3 GEL® System. TYBR Health raised a $30 million Series A in July 2026, bringing total disclosed funding to $30 million, with the round intended to expand access to the product.
Funding History
TYBR Health Announces $30 Million Series A Financing to Expand Access to the B3 GEL® System
Frequently Asked Questions
- How much funding does AI Funding track for TYBR Health?
- AI Funding tracks $30M for TYBR Health across 1 funding round in this database.
- What does TYBR Health do?
- TYBR Health builds the B3 GEL® System, a healthcare technology product positioned for clinical use and broader patient access. The company targets healthcare providers and care settings that can adopt the system as part of patient treatment workflows. The company’s key disclosed differentiator is its proprietary B3 GEL® System. TYBR Health raised a $30 million Series A in July 2026, bringing total disclosed funding to $30 million, with the round intended to expand access to the product.
- Where is TYBR Health headquartered?
- TYBR Health is headquartered in Houston, United States.
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.